DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
169 hedge funds and large institutions have $1.02B invested in DermTech, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 97 funds opening new positions, 43 increasing their positions, 20 reducing their positions, and 13 closing their positions.
646% more first-time investments, than exits
New positions opened: 97 | Existing positions closed: 13
167% more capital invested
Capital invested by funds: $381M → $1.02B (+$635M)
115% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 20
99% more funds holding
Funds holding: 85 → 169 (+84)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
24% more call options, than puts
Call options by funds: $35M | Put options by funds: $28.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
ISZO Capital Management
New York
|
+$70.5M |
| 2 |
State Street
Boston,
Massachusetts
|
+$50.1M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$41.8M |
| 4 |
BlackRock
New York
|
+$27.1M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$24.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$34.6M |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$8.52M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$7.68M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.62M |
| 5 |
BM
Bridger Management
New York
|
-$3M |
DMTK Hedge Fund Activity: Q1 2021 in Review
169 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q1 2021, worth a combined $1.02B — up 167% from $381M a quarter earlier.
Buyers outnumbered sellers: 97 funds opened new DMTK positions and 13 closed out — a net gain of 84 holders — while 43 added to existing stakes and 20 trimmed.
The largest buyer was ISZO Capital Management, adding an estimated $70.5M. The largest seller was Farallon Capital Management, cutting an estimated $34.6M.
- 169 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q1 2021, up from 85 in Q4 2020.
- Funds reported $1.02B of DermTech, Inc. Common Stock stock for Q1 2021, up 167% quarter-over-quarter.
- 97 funds opened new DermTech, Inc. Common Stock positions in Q1 2021 and 13 closed out, a net change of +84 holders.
- The largest DermTech, Inc. Common Stock buyer in Q1 2021 was ISZO Capital Management, an estimated $70.5M added.
- The largest DermTech, Inc. Common Stock seller in Q1 2021 was Farallon Capital Management, an estimated $34.6M sold.
Based on aggregated 13F filings for Q1 2021.